© 1997 American Heart Association, Inc.
Articles |
Endogenous Nitric Oxide Masks 
2-Adrenergic Coronary Vasoconstriction During Exercise in the Ischemic Heart
the Cardiovascular Division (R.J.B.), Department of Medicine, University of Minnesota Medical School, Minneapolis; 89-1 Enyachou (Y.I.), Izumo City, Shimane Prefecture, Japan; and the Laboratory for Experimental Cardiology (D.J.D.), Thoraxcentre, Erasmus University, Rotterdam, the Netherlands.
Correspondence to Robert J. Bache, MD, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Box 508 UMHC, 420 Delaware St SE, Minneapolis, MN 55455. E-mail Bache001@maroon.tc.umn.edu
Previously, we observed that 1- but not 2-adrenergic vasoconstriction restricted blood flow distal to a coronary artery stenosis that resulted in myocardial hypoperfusion during exercise. This study was performed to test the hypothesis that vascular smooth muscle 2-adrenergic vasoconstriction during exercise does exert a flow-limiting effect distal to a coronary artery stenosis but that this action is counterbalanced by simultaneous endothelial 2-adrenergic stimulation of NO production. Eight dogs instrumented with a Doppler velocity probe, hydraulic occluder, and indwelling microcatheter in the left anterior descending coronary artery (LAD) were studied during treadmill exercise in the presence of a coronary artery stenosis before and during infusion of the 2-adrenergic receptor antagonist idazoxan (1.0 µg·kg-1·min-1 IC) before and after NO synthase blockade with NG-monomethyl-L-arginine (LNNA, 1.5 mg/kg IC). Coronary pressure distal to the stenosis was maintained constant during the control period and after administration of idazoxan before and after LNNA. Neither idazoxan nor LNNA altered any of the systemic hemodynamic variables either at rest or during exercise. During exercise in the absence of a stenosis, idazoxan and LNNA had no effect on coronary blood flow. In the presence of a stenosis that decreased distal coronary pressure to 52±3 mm Hg, mean myocardial blood flow measured with microspheres was 0.87±0.17 mL·min-1·g-1 in the LAD-dependent region and 2.52±0.30 mL·min-1·g-1 in the posterior control region, respectively. With no change in distal coronary pressure, idazoxan had no effect on mean myocardial blood flow in the LAD region (0.86±0.17 mL·min-1·g-1), but LNNA decreased mean myocardial blood flow to 0.49±0.09 (P<.01). However, when idazoxan was infused during exercise in the presence of a coronary artery stenosis after LNNA administration, idazoxan increased mean myocardial blood flow to 0.62±0.13 mL·min-1·g-1 (P<.01). These data demonstrate that 2-adrenergic stimulation of endothelial NO production, which occurs during exercise in the presence of a flow-limiting coronary artery stenosis, acts to counterbalance vascular smooth muscle 2-adrenergic vasoconstriction.
Key Words: coronary vasodilation • endothelium • NG-nitro-L-arginine • idazoxan • adrenergic vasoconstriction
This article has been cited by other articles:
 |
|
 |
|
  D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Duling, T. W. Cherng, J. R. Griego, M. F. Perrine, and N. L. Kanagy Loss of {alpha}2B-adrenoceptors increases magnitude of hypertension following nitric oxide synthase inhibition Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2403 - H2408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Huang, M. H. Weil, S. Sun, W. Tang, and X. Fang Carvedilol Mitigates Adverse Effects of Epinephrine During Cardiopulmonary Resuscitation Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2005; 10(2): 113 - 120. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Setty, W. Sun, R. Martinez, H. F. Downey, and J. D. Tune {alpha}-Adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus J Appl Physiol, July 1, 2004; 97(1): 431 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cao, M. H. Weil, S. Sun, and W. Tang Vasopressor Agents for Cardiopulmonary Resuscitation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 115 - 121. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Vandier, J.-Y. Le Guennec, and G. Bedfer WHAT ARE THE SIGNALING PATHWAYS USED BY NOREPINEPHRINE TO CONTRACT THE ARTERY? A DEMONSTRATION USING GUINEA PIG AORTIC RING SEGMENTS Advan Physiol Educ, September 1, 2002; 26(3): 195 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia Circulation, November 6, 2001; 104(19): 2305 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Seasholtz, G. Cai, H.-Y. Wang, and E. Friedman Signal Transduction in Smooth Muscle: Selected Contribution: Effects of ischemia-reperfusion on vascular contractility and {alpha}1-adrenergic-receptor signaling in the rat tail artery J Appl Physiol, August 1, 2001; 91(2): 1004 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sun, M. H. Weil, W. Tang, T. Kamohara, and K. Klouche Alpha-methylnorepinephrine, a selective alpha2-adrenergic agonist for cardiac resuscitation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 951 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsumoto, H. Tachibana, Y. Ogasawara, and F. Kajiya New double-tracer digital radiography for analysis of spatial and temporal myocardial flow heterogeneity Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H465 - H474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Traverse, Y. J. Chen, R. Du, and R. J. Bache Cyclic Nucleotide Phosphodiesterase Type 5 Activity Limits Blood Flow to Hypoperfused Myocardium During Exercise Circulation, December 12, 2000; 102(24): 2997 - 3002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, R. Du, J. H. Traverse, and R. J. Bache Effect of sildenafil on coronary active and reactive hyperemia Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2319 - H2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Szentivanyi Jr, A.-P. Zou, C. Y. Maeda, D. L. Mattson, and A. W. Cowley Jr Increase in Renal Medullary Nitric Oxide Synthase Activity Protects From Norepinephrine-Induced Hypertension Hypertension, January 1, 2000; 35(1): 418 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Duncker, J. H. Traverse, Y. Ishibashi, and R. J. Bache Effect of NO on transmural distribution of blood flow in hypertrophied left ventricle during exercise Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1305 - H1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Thomas, M. Sander, K. S. Lau, P. L. Huang, J. T. Stull, and R. G. Victor Impaired metabolic modulation of alpha -adrenergic vasoconstriction in dystrophin-deficient skeletal muscle PNAS, December 8, 1998; 95(25): 15090 - 15095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Kanagy Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2756 - H2764. [Abstract] [Full Text] [PDF]
|
|